Wolf Group Capital Advisors Gsk PLC Transaction History

Wolf Group Capital Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 22, 2019	SELL	$38.57 - $42.69 $1.23 Million - $1.36 Million	-31,795 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$37.8 - $42.69 $567 - $640	15 Added 0.05%	31,795 $1.22 Million
Q3 2018 Oct 23, 2018	SELL	$39.75 - $42.69 $88,841 - $95,412	-2,235 Reduced 6.57%	31,780 $1.28 Million
Q2 2018 Jul 12, 2018	BUY	$39.61 - $42.76 $72,407 - $78,165	1,828 Added 5.68%	34,015 $1.37 Million
Q1 2018 Apr 25, 2018	BUY	$36.18 - $40.15 $184,988 - $205,286	5,113 Added 18.89%	32,187 $1.26 Million
Q4 2017 Feb 12, 2018	SELL	$35.34 - $41.9 $8,163 - $9,678	-231 Reduced 0.85%	27,074 $960,000
Q3 2017 Oct 23, 2017	SELL	$39.44 - $41.55 $487,241 - $513,308	-12,354 Reduced 31.15%	27,305 $1.12 Million
Q2 2017 Aug 09, 2017	BUY	N/A	39,659	39,659 $1.71 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Wolf Group Capital Advisors with notifications on news.